We are live on ! Find out more
MDVX

Medovex Corp. Common Stock
MDVX

Delisted

MDVX was delisted on the 15th of November, 2017.

Back to rankings

6 hedge funds and large institutions have $57K invested in Medovex Corp. Common Stock in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 4 → 6 (+2)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.02% less ownership

Funds ownership: 0.15% → 0.13% (-0.02%)

16% less capital invested

Capital invested by funds: $68K → $57K (-$11K)

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$3.67K
2
Morgan Stanley
Morgan Stanley
New York
+$75
3
Citigroup
Citigroup
New York
+$28

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$13.1K

MDVX Hedge Fund Activity: Q2 2015 in Review

6 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Medovex Corp. Common Stock (MDVX) for Q2 2015, worth a combined $57K — down 16% from $68K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new MDVX positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Tower Research Capital (TRC), adding an estimated $3.67K. The largest seller was UBS Group, cutting an estimated $13.1K.

  • 6 institutional investors held Medovex Corp. Common Stock (MDVX) as of Q2 2015, up from 4 in Q1 2015.
  • Funds reported $57K of Medovex Corp. Common Stock stock for Q2 2015, down 16% quarter-over-quarter.
  • 2 funds opened new Medovex Corp. Common Stock positions in Q2 2015 and 0 closed out, a net change of +2 holders.
  • The largest Medovex Corp. Common Stock buyer in Q2 2015 was Tower Research Capital (TRC), an estimated $3.67K added.
  • The largest Medovex Corp. Common Stock seller in Q2 2015 was UBS Group, an estimated $13.1K sold.

Based on aggregated 13F filings for Q2 2015.